Web Analytics

fundsforNGOs

Grants and Resources for Sustainability

You are here: Home / Grant / RFPs: Generic Call for Proposal HIV/AIDS, Stis, Viral Hepatitis, Tuberculosis (France)

RFPs: Generic Call for Proposal HIV/AIDS, Stis, Viral Hepatitis, Tuberculosis (France)

Deadline: 17-Mar-2026

The ANRS MIE has opened the first session of its 2026 biannual call for generic research projects targeting HIV/AIDS, sexually transmitted infections, viral hepatitis, and tuberculosis. Funding supports basic, translational, clinical, and public health research, including co-infections, implementation science, and prevention strategies, with project durations from 12 to 36 months and equipment support capped at €20,000 per team.

About the Call

The ANRS MIE generic project call aims to advance research on major infectious diseases while mobilizing resources toward high-priority areas. This initiative encourages studies addressing co-infections, the impact of other diseases on care and prevention, and innovative strategies to control HIV/AIDS, viral hepatitis, and tuberculosis.

Research Priorities

The call focuses on key themes, including:

  • Prevention of mother-to-child transmission of HIV/AIDS, viral hepatitis, and congenital syphilis.

  • Screening and non-vaccine biomedical/non-biomedical prevention of HIV/AIDS and STIs.

  • Cure strategies for HIV/AIDS, HBV, and HDV infections.

  • Novel therapeutic approaches for tuberculosis.

  • Implementation and scaling-up of interventions in public health contexts.

Eligible Research Areas

Projects may include:

  • Basic research on pathogens, host responses, and disease mechanisms.

  • Translational research bridging lab discoveries and clinical applications.

  • Clinical studies including trials or observational studies (up to 60 months for certain clinical studies).

  • Public health research examining screening, prevention, or health system interventions.

  • Human and social sciences research related to infectious disease prevention, care, or policy.

Excluded Projects: Projects that fall under the ANRS-VRI vaccine research program.

Funding Details

  • Equipment funding limit: €20,000 per project team.

  • Project durations:

    • Standard projects: 12–36 months

    • Clinical studies: up to 60 months

    • Initiation contracts (feasibility or preliminary studies): 12 months

  • Types of support: Research grants, initiation contracts, project-linked doctoral and postdoctoral grants.

Eligibility

  • Applicants: French public or private research laboratories contributing to higher education and research missions.

  • Collaborations: International partnerships are allowed if the coordinating team is based in a French research establishment.

  • Doctoral/Postdoctoral Grants: Applicants must be attached to a French research organization.

Application Process

  1. Submission Platform: Applications must be submitted online.

  2. Required Documentation:

    • Administrative details of the research team and institutions

    • Scientific project presentation

    • Full-cost budget with anticipated expenses and funding sources

    • For resubmissions, a detailed point-by-point response to prior evaluation feedback

  3. Co-Financing: Allowed with other funding agencies if objectives do not overlap.

  4. Acknowledgment: All outputs must recognize ANRS Emerging Infectious Diseases support.

Key Dates

  • Application Deadline: 17 March 2026

  • Results Announcement: July 2026

  • Funding Start: Several months post-announcement, pending administrative, ethical, and regulatory approvals.

Project Management & Reporting

  • Grants: Allocated to the managing organization of each project team.

  • Responsibilities: Financial management, reporting, and compliance with ANRS obligations.

Tips for a Strong Application

  • Clearly define research objectives and expected impact.

  • Ensure alignment with ANRS MIE priority areas.

  • Provide a comprehensive budget detailing all costs, including equipment within the €20,000 limit.

  • If resubmitting, address prior reviewers’ comments thoroughly.

  • Demonstrate the potential for collaboration, innovation, and scientific advancement.

Conclusion

The ANRS MIE 2026 generic project call is a strategic opportunity for French research teams to advance knowledge and interventions against HIV/AIDS, STIs, viral hepatitis, and tuberculosis. By supporting diverse research types—from basic science to implementation studies—the program strengthens France’s contributions to global infectious disease research and public health solutions.

For more information, visit ANRS MIE.